Development of the ex vivo laryngeal model of phonation

被引:4
|
作者
Howard, N. Scott [1 ]
Mendelsohn, Abie H. [2 ]
Berke, Gerald S. [2 ]
机构
[1] San Antonio Mil Med Ctr, Dept Otolaryngol Head & Neck Surg, San Antonio, TX USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90024 USA
来源
LARYNGOSCOPE | 2015年 / 125卷 / 06期
基金
美国国家卫生研究院;
关键词
Human; canine; larynx; perfusion; physiology; voice; VOCAL FOLDS; CANINE; MUSCLE; VOICE;
D O I
10.1002/lary.25149
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/HypothesisThe direct study of human phonation is limited by the invasive and painful nature of human laryngeal neuromuscular manipulation. As a platform for the study of human phonation, indirect models have been utilized for decades such as animal, cadaveric, and computational. We sought to develop a research method allowing direct scientific control of virtually living larynges to expand our ability to understand human phonation. Study DesignCanine and porcine models. MethodsNineteen canine larynges were surgically removed and reperfused with progressively adapting methodologies to create ex vivo phonation. ResultsFull neuromuscular stimulation and phonation were ultimately achieved in the ex vivo larynx. As compared with alternative perfusate solutions, heparinized whole blood was found to result in the most robust neuromuscular response. Modification of the reperfusion technique from a continuous flow to a pulsatile pump system resulted in dramatic increases in neuromuscular response and longevity of the organ. The experimental findings were repeated to demonstrate reliability of the ex vivo model. ConclusionsThe ex vivo larynx model is demonstrated to be a repeatable platform for phonatory research. The process of development has been comprehensively described in the present report. Although the described experimental model was designed for phonatory research, this model can be readily adapted for investigations of organ transplant preservation techniques, effects of organ ischemia, and neuromuscular reinnervation capabilities. Level of EvidenceNA Laryngoscope, 125:1414-1419, 2015
引用
收藏
页码:1414 / 1419
页数:6
相关论文
共 50 条
  • [41] Laryngeal Phonation after Tracheoesophageal Diversion
    Yu A. Chiba
    Shinichi Nishio
    Akira Yamaguchi
    Fumio Eto
    Dysphagia, 2005, 20 : 235 - 237
  • [43] PHONATION QUOTIENT IN PATIENTS WITH LARYNGEAL DISEASES
    IWATA, S
    LEDEN, HV
    FOLIA PHONIATRICA, 1970, 22 (02): : 117 - 128
  • [44] Acoustic Impact of Ventricular Folds on Phonation Studied in Ex Vivo Human Larynx Models
    Birk, V.
    Sutor, A.
    Doellinger, M.
    Bohr, C.
    Kniesburges, S.
    ACTA ACUSTICA UNITED WITH ACUSTICA, 2016, 102 (02) : 244 - 256
  • [45] EFFECT OF SUPERIOR LARYNGEAL NERVE-STIMULATION ON PHONATION IN AN INVIVO CANINE MODEL
    BERKE, GS
    MOORE, DM
    GERRATT, BR
    HANSON, DG
    NATIVIDAD, M
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1989, 10 (03) : 181 - 187
  • [46] THE EFFECT OF RECURRENT LARYNGEAL NERVE-STIMULATION ON PHONATION IN AN INVIVO CANINE MODEL
    BERKE, GS
    MOORE, DM
    GERRATT, BR
    HANSON, DG
    BELL, TS
    NATIVIDAD, M
    LARYNGOSCOPE, 1989, 99 (09): : 977 - 982
  • [47] Ex-vivo Mechanical Testing of Novel Laryngeal Clamps Used for Laryngeal Advancement Constructs
    Grzeskowiak, Remigiusz M.
    Schumacher, James
    Mulon, Pierre-Yves
    Steiner, Richard C.
    Cassone, Lynne
    Anderson, David E.
    FRONTIERS IN VETERINARY SCIENCE, 2020, 7
  • [48] Ex vivo model for xenotransplantation
    Fiane, AE
    Videm, V
    Scholz, T
    Pedersen, T
    Karlsen, H
    Geiran, O
    Foerster, A
    Mollnes, T
    Aasen, AO
    Svennevig, J
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3560 - 3561
  • [49] Ex Vivo Bone Model
    不详
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2013, 41 (02): : 148 - 148
  • [50] Development of an ex vivo model for pharmacological experimentation on isolated tissue preparation
    Jain, Gaurav
    Bodakse, Surendra H.
    Namdev, Kantaprasad
    Rajput, Mithun S.
    Mishra, Saurabh
    JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2012, 3 (03) : 176 - 181